Intrauterine Balloon Tamponade Improves Hemorrhage Control
By HospiMedica International staff writers Posted on 11 Jan 2018 |
Image: An intrauterine balloon tamponade device (Photo courtesy of Alpha Image).
A new study shows that using an intrauterine balloon is associated with a significantly lower need for invasive procedures for hemorrhage control in women following vaginal delivery.
Researchers at Université de Versailles Saint-Quentin-en-Yvelines (UVSQ; France) conducted a retrospective cohort study that included 72,529 women who delivered a baby during 2011 and 2012 in 19 maternity units in two French perinatal networks; one that routinely used an intrauterine balloon tamponade for postpartum hemorrhage management (study cohort), and another that did not (control). Postpartum outcomes were assessed based on discharge abstract data from the French national medical information system.
The results revealed that invasive procedures were assumed in 298 women, representing 4.1 per 1,000 deliveries. The cohort network had a significantly lower proportion of women with at least one invasive procedure (3/1,000), compared to the control network (5.1/1,000). The study perinatal network also had significantly lower use of arterial embolization for those who delivered vaginally. Risk of an invasive procedure remained significantly lower in the cohort network for women who delivered vaginally, but not for women who delivered by Cesarean section. The study was published on December 4, 2017, in Obstetrics & Gynecology.
“The use of intrauterine balloon tamponade in routine clinical practice is associated with a significantly lower use of invasive procedures among women undergoing vaginal delivery,” concluded lead author Mathilde Revert, MSc, and colleagues. “After controlling for potential confounding factors, the risk of an invasive procedure among women who delivered vaginally remained significantly lower in the pilot network, but not for women who delivered by Cesarean.”
Postpartum hemorrhage is the leading direct cause of maternal death worldwide. Intrauterine balloon tamponade is a minimally invasive intervention that involves inserting a balloon device into the uterus and then incrementally filling it with liquid, which applies pressure to the uterus until the bleeding stops. Even when it cannot completely control severe postpartum hemorrhage, it can still serve a critical role by reducing blood loss until the woman can be transported to a facility with surgical management and other treatment options.
Related Links:
Université de Versailles Saint-Quentin-en-Yvelines
Researchers at Université de Versailles Saint-Quentin-en-Yvelines (UVSQ; France) conducted a retrospective cohort study that included 72,529 women who delivered a baby during 2011 and 2012 in 19 maternity units in two French perinatal networks; one that routinely used an intrauterine balloon tamponade for postpartum hemorrhage management (study cohort), and another that did not (control). Postpartum outcomes were assessed based on discharge abstract data from the French national medical information system.
The results revealed that invasive procedures were assumed in 298 women, representing 4.1 per 1,000 deliveries. The cohort network had a significantly lower proportion of women with at least one invasive procedure (3/1,000), compared to the control network (5.1/1,000). The study perinatal network also had significantly lower use of arterial embolization for those who delivered vaginally. Risk of an invasive procedure remained significantly lower in the cohort network for women who delivered vaginally, but not for women who delivered by Cesarean section. The study was published on December 4, 2017, in Obstetrics & Gynecology.
“The use of intrauterine balloon tamponade in routine clinical practice is associated with a significantly lower use of invasive procedures among women undergoing vaginal delivery,” concluded lead author Mathilde Revert, MSc, and colleagues. “After controlling for potential confounding factors, the risk of an invasive procedure among women who delivered vaginally remained significantly lower in the pilot network, but not for women who delivered by Cesarean.”
Postpartum hemorrhage is the leading direct cause of maternal death worldwide. Intrauterine balloon tamponade is a minimally invasive intervention that involves inserting a balloon device into the uterus and then incrementally filling it with liquid, which applies pressure to the uterus until the bleeding stops. Even when it cannot completely control severe postpartum hemorrhage, it can still serve a critical role by reducing blood loss until the woman can be transported to a facility with surgical management and other treatment options.
Related Links:
Université de Versailles Saint-Quentin-en-Yvelines
Latest Surgical Techniques News
- Porous Gel Sponge Facilitates Rapid Hemostasis and Wound Healing
- Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery
- Robotic Nerve ‘Cuffs’ Could Treat Various Neurological Conditions
- Flexible Microdisplay Visualizes Brain Activity in Real-Time To Guide Neurosurgeons
- Next-Gen Computer Assisted Vacuum Thrombectomy Technology Rapidly Removes Blood Clots
- Hydrogel-Based Miniaturized Electric Generators to Power Biomedical Devices
- Custom 3D-Printed Orthopedic Implants Transform Joint Replacement Surgery
- Wearable Technology Monitors and Analyzes Surgeons' Posture during Long Surgical Procedures
- Cutting-Edge Imaging Platform Detects Residual Breast Cancer Missed During Lumpectomy Surgery
- Computational Models Predict Heart Valve Leakage in Children
- Breakthrough Device Enables Clear and Real-Time Visual Guidance for Effective Cardiovascular Interventions
- World’s First Microscopic Probe to Revolutionize Early Cancer Diagnosis
- World’s Smallest Implantable Brain Stimulator Demonstrated in Human Patient
- Robotically Assisted Lung Transplants Could Soon Become a Reality
- AI to Provide Heart Transplant Surgeons with New Decision-Making Data
- New Surgical Tool Empowers Precision and Confidence in Operating Room